Caplin Steriles receives USFDA approval for new products
Caplin Steriles receives USFDA approval for new products

Caplin Steriles receives USFDA approval for new products

Shruti Dahiwal Article rating: 3.6

Caplin Steriles Limited, a subsidiary company of Caplin Point Laboratories Limited announced this morning that it has been granted approval from USFDA for its abbreviated new drug application (ANDA) Prochlorperazine Edisylate injection USP, 10 mg/2 ml (5 mg/ml) vials presentations.

Tata Elxsi zooms to lifetime high
Tata Elxsi zooms to lifetime high

Tata Elxsi zooms to lifetime high

Geyatee Deshpande Article rating: 4.6

Tata Elxsi is turning out to be a star performer from the pack of Tata Group stocks. The stock jumped more than eight per cent on Friday, trading at Rs 3,291.55 per share.   

Alembic Pharma gets US regulator nod for Doxepin Hydrochloride capsules
Alembic Pharma gets US regulator nod for Doxepin Hydrochloride capsules

Alembic Pharma gets US regulator nod for Doxepin Hydrochloride capsules

Anthony Fernandes Article rating: 5.0

On Friday, Alembic Pharmaceuticals informed the exchanges that it has received final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Doxepin Hydrochloride capsules, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg & 100 mg.  

LT Foods gains on expansion in Australia and UAE
LT Foods gains on expansion in Australia and UAE

LT Foods gains on expansion in Australia and UAE

Abhinav Lahoti Article rating: 3.7

Kameda Seika, Japan’s largest rice crackers company as well as LT Foods’ joint venture company has started exporting Kari Kari in the markets of Australia & UAE.

Buzzing stock: Orient Refractories trades at all-time high level
Buzzing stock: Orient Refractories trades at all-time high level

Buzzing stock: Orient Refractories trades at all-time high level

Apurva Joshi Article rating: 4.8

In just one year, Orient Refractories Limited has rallied by approximately 147 per cent making an all-time high level of Rs 319.20 from its 52-week low level of Rs 129.50 on BSE. On a YTD basis, this stock has given approximately 27 per cent returns to the investors. 

Five stocks witnessing long built-up
Five stocks witnessing long built-up

Five stocks witnessing long built-up

Ganesh Pawar Article rating: 3.8

The market opened in red on April 23, 2021, overall volumes in futures & options currently stand at 9,98,78,806 contracts with a turnover of Rs. 88,49,231.75 crore.

RSS
First18961897189818991901190319041905Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR